Isotopes for isotopically labeling proteins for solution Nuclear Magnetic Resonance (NMR) investigation
Cancelled Solicitation Posted
- Solicitation number
- 75N94025Q00177
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH), specifically the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on behalf of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is seeking to procure specialized isotopes for isotopically labeling proteins for solution Nuclear Magnetic Resonance (NMR) investigation. The procurement requires specific quantities of D-Glucose variants and ammonium chloride, including 2 units of D-Glucose (U-13C6, 99%), 10 units of D-Glucose (U-13C6, 99%; 1,2,3,4,5,6,6-D7, 97-98%), 5 units of D-Glucose (1,2,3,4,5,6,6-D7, 97-98%), and 10 units of ammonium chloride (15N, 99%). The government intends to award a Firm Fixed Price (FFP) purchase order through full and open competition using Lowest Price Technically Acceptable (LPTA) evaluation criteria. This Request for Quotation (RFQ) was posted on August 11, 2025, with quotes due by August 18, 2025, providing vendors with a seven-day response window. The acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures for commercial products and services.
This solicitation is not set aside for small businesses and operates under the North American Industry Classification (NAICS) Code 325412 with a size standard of 1,300 employees, making it available to businesses of all sizes through full and open competition. While specific contract values are not disclosed in the documentation, the procurement involves precise quantities of specialized isotopic materials that must be delivered by October 2025. The base performance period runs from September 1 to October 1, 2025, with required delivery of all isotopes completed within this timeframe. The place of performance is designated as Bethesda, MD 20892, which corresponds to the NIH campus location. Payment will be made in one lump sum according to NIH Invoicing Instructions, and vendors must comply with various federal acquisition regulations including sustainable product requirements and commercial contract terms and conditions.
Notice text
This is a combined synopsis/solicitation for commercial products or services prepared in accordance with the format in FAR 12.6 (Streamlined Procedures for Evaluation and Solicitation for commercial items) as applicable, and as supplemented with additional information included in this notice. This acquisition will be processed in accordance with FAR Part 13 – Simplified Acquisition Procedures (SAP) for Certain Commercial Products and Services. This announcement constitutes the solicitation; quotes are being requested and a separate written solicitation will not be issued. This solicitation number is 75N94025Q00177 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2025-04 (May 12, 2025).
The North American Industry Classification (NAICS) Code is 325412 and the business size standard is 1,300 employees.
This solicitation is NOT set aside for total small businesses.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on behalf of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to award a Firm Fixed Price (FFP) purchase order through full and open competition to fulfill this requirement.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Clinical Research Support and Collaboration for NHGRI Protocols | Office of Logisitics and Acquisition Operations | Total Small Business | |
| CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap) | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| NCSS - Bioruptor Pico Sonication Device | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity